InMed Pharmaceuticals Inc.INMNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR+97.4%
5Y CAGR-52.9%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+97.4%/yr
vs -74.4%/yr prior
5Y CAGR
-52.9%/yr
Recent acceleration
Acceleration
+171.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.17+13.8%
20240.15+7.4%
20230.14+528.8%
20220.02-99.0%
20212.34-68.5%
20207.44+79.9%
20194.14-20.8%
20185.22-0.4%
20175.24-29.1%
20167.40-